The Latin America Flow Cytometry market is expected to reach USD 379 million by 2027 from USD 269 million in 2022 at a CAGR of 7.1% during the forecast period. Factors such as growing prevalence of cancer and HIV/ AIDS, growing adoption of flow cytometry techniques in research activities, and increasing number of technological advancements in the flow cytometry instruments and software are prominently driving the market growth. However, the high cost of flow cytometry products such as instruments and consumables is the major factor expected to restrain market growth to a certain extent.
The Latin American flow cytometry market is highly consolidated. Prominent market players include Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories Inc. (US), Miltenyi Biotec GmbH (Germany), Luminex Corporation (US). These companies offer a wide range of flow cytometry products as well as services focusing on innovating. However, the high market consolidation acts as a barrier for new entrants in the market.
To know about the assumptions considered for the study download the pdf brochure
Becton, Dickinson and Company (US) is the leading player in the Latin American flow cytometry market. The company has a comprehensive flow cytometry product portfolio. BD focuses on innovating technologically and has been launching products consistently. For instance, the company launched the FACSymphony A5 SE Cell Analyzer. This fluorescence-activated and spectral-enabled cell analyzer allows researchers to choose between spectral or compensation-based cell analysis to meet different flow cytometry needs. The company dominates the flow cytometry market in Latin America due to factors such as the high reliability of diagnostic centres and other end user on BD products and the company’s strong image as a brand. Besides, the company maintains a strong geographic presence in Latin American countries through a wide and well-established network of distributors. The company is highly focused on consistency in the quality of its products & services and efficient adaptation in new business environments.
Danaher Corporation (US) is one of the leading players in the flow cytometry market in Latin America. Danaher offers products & services for medical, industrial and commercial applications through Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions business segments. The company is focused on growing through developments such as product launches and acquisitions. In June 2011, Danaher (US) acquired Beckman Coulter, Inc. The company offers flow cytometry products through Beckman Coulter, Inc. Beckman Coulter adds to Danaher’s revenue growth through innovative research, advancement, expansion, and the launch of novel flow cytometry products. Between 2019 and 2021, Beckman Coulter registered many acquisitions and product launches in the flow cytometry market. This has led to the company establishing a strong position in the global as well as the Latin American Market.
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE